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A randomised controlled trial was undertaken to assess the effectiveness of a hospital Palliative Care Team (PCT) on physical
symptoms and health-related quality of life (HRQoL); patient, family carer and primary care professional reported satisfaction
with care; and health service resource use. The full package of advice and support provided by a multidisciplinary specialist
PCT (‘full-PCT’) was compared with limited telephone advice (‘telephone-PCT’, the control group) in the setting of a teaching
hospital trust in the SW of England. The trial recruited 261 out of 684 new inpatient referrals; 175 were allocated to ‘full-PCT’,
86 to ‘telephone-PCT’ (2:1 randomisation); with 191 (73%) being assessed at 1 week. There were highly signiﬁcant
improvements in symptoms, HRQoL, mood and ‘emotional bother’ in ‘full-PCT’ at 1 week, maintained over the 4-week
follow-up. A smaller effect was seen in ‘telephone-PCT’; there were no signiﬁcant differences between the groups. Satisfaction
with care in both groups was high and there was no signiﬁcant difference between them. These data reﬂect a high standard of
care of patients dying of cancer and other chronic diseases in an acute hospital environment, but do not demonstrate a
difference between the two models of service delivery of specialist palliative care.
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Over the past 30 years in the UK there has been substantial expansion
of palliative care services. Initially this was largely driven by the
voluntary sector, but in recent years there has been not only endorse-
ment by government but substantial investment. Specialist palliative
care is now a required core service of every cancer network, and the
UK government, in its recently published Cancer Plan (Department
of Health, 2000), commits itself to improving equity of access to such
services. Paradoxically, as specialist palliative care comes into the
mainstream of health care, robust evidence of effectiveness is lacking.
There are difﬁculties in producing such evidence which have been
well rehearsed in recent years (McQuay and Moore, 1994; Keeley,
1999). In particular, there have been few successfully completed
randomised controlled trials (RCTs) (Rinck et al, 1997) and most
of these have failed to demonstrate unequivocal beneﬁts of specialist
palliative care services when compared with usual care (Kane et al,
1985; Grande et al, 1999; Jourdhoy et al, 2000). Even where differ-
ences have been shown the gain has been modest. There have not,
however, been any RCTs of hospital-based specialist palliative care.
This is in spite of the fact that in the UK (and in several other coun-
tries) the biggest growth in palliative care services has been in the
general hospital sector. Hospital-based ‘support’ teams are now
widely established in district general hospitals and more services
are being rolled out across the country. A report to the UK Depart-
ment of Health in March 2000 revealed that 65% of acute hospitals
had a specialist palliative care service (Clinical Standards Advisory
Group, 2000), though these services varied considerably in their
structure and available facilities.
We report here the ﬁrst randomised controlled trial to evaluate a
hospital specialist Palliative Care Team (PCT). The aim of the
study was to compare outcomes (primarily symptom control,
health-related quality of life (HRQoL), duration of hospital admis-
sion and rate of re-admission) in patients randomised to receive
one of two models of advice and support from a multidisciplinary
specialist PCT providing a package of care in addition to the usual
care given in a university teaching hospital.
METHODS
Setting
The United Bristol Healthcare Trust (UBHT) comprises the Bristol
Royal Inﬁrmary with 433 beds and associated specialist hospitals
providing services in oncology, ophthalmology, dentistry, otorhino-
laryngology, paediatrics, and obstetrics and gynaecology. The
oncology service sees nearly 4000 new patients a year. Within
UBHT, the PCT has provided an advisory and consultancy service
to hospital staff and patients since 1992. Any patient with palliative
care needs can be referred to the PCT, with the consent of the
patient’s consultant. Patients with cancer or non-malignant
illnesses are referred for symptom relief and pain control;
emotional and psychological support for patients, carers and ward
staff; patient discharge planning; social and ﬁnancial advice; and
bereavement support for carers. As well as providing a clinical
service, the PCT undertakes a wide range of teaching including
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www.bjcancer.comstudy days for nurses, provision of teaching modules within the
undergraduate medical curriculum and postgraduate degree
courses and supervision.
The study was approved by the UBHT local research ethics
committee.
Study population
All new inpatient referrals to the PCT were assessed for entry into
the study. Initially only patients with cancer were included, but
following a pilot study, all diagnostic groups were admitted, since
non-cancer patients represent a signiﬁcant proportion of the total
(10%).
Referrals were received by a member of the PCT, who conﬁrmed
with the referring doctor or nurse that the patient was eligible for
the study. Patients were excluded if they were unable to give
informed consent, were not well enough to undertake the baseline
assessment, were not aware of their diagnosis, were likely to die or
be discharged within 24 h, or needed advice very urgently. Patients
who expressed a strong preference to see the PCT or whose refer-
ring consultant ‘insisted’ that they be seen were also excluded. If
the member of the PCT receiving the referral judged that the
patient, their family or the ward staff were in ‘extreme distress’
the patient was excluded.
Eligible patients were visited by a researcher within 24 h of
referral, to explain the study and obtain written informed consent.
Patients were then randomised. The researchers who undertook the
assessments were blind to the group allocation.
The interventions
The full PCT service (‘full-PCT’) This was the usual service
delivered by the PCT, which during the study comprised two clin-
ical academic consultants, one specialist registrar and three clinical
nurse specialists (2.5 full-time equivalents). The PCT has close
links with a clinical psychologist, a local hospice and community
based palliative care services and access to social workers, rehabili-
tation staff and the chaplaincy in the hospital. Initial assessment of
patients was undertaken by a specialist doctor or specialist nurse,
either alone or together, and detailed advice about any problems
identiﬁed was written in the patient’s case notes and communi-
cated to the patient’s medical and nursing team personally or by
telephone. Appropriate follow-up was then instituted which usually
involved both telephone and in-person consultations with the
patient, their family and the medical and nursing staff caring for
the patient by one of the specialist nurses or the registrar. All
patients were reviewed at least weekly by one of the consultants.
For patients who were discharged from hospital, the PCT also
provided liaison with community based health professionals and
outpatient follow-up in the Palliative Care clinic if appropriate.
The control group (‘telephone-PCT’) A more limited form of
intervention was devised as a control. This involved no direct
contact between the PCT and the patient or their family. Instead,
within one working day of referral, a telephone consultation took
place between a senior medical member of the PCT and the refer-
ring doctor and also between a PCT nurse specialist and a member
of the ward nursing staff directly involved with the patient. A
second telephone consultation could be made if necessary but
thereafter no further follow-up or advice was given. Such a tele-
phone advisory service commonly forms a part of the
operational policy of specialist palliative care teams.
Outcomes
The primary follow-up time was set at 1 week post-recruitment in
order to maximise completeness of data. The four primary
outcomes were: symptom control (including the severity of the
most bothersome symptom identiﬁed by patients, mood, and
emotional bother); HRQoL; and length of hospital stay and rate
of re-admission. Secondary outcomes included satisfaction of
patients, family carers and primary health care professionals; and
use of health service resources.
Symptom control and HRQoL HRQoL was measured by the
EORTC QLQ-C30 questionnaire (items 29 and 30) (Aaronson et
al, 1993); severity of most bothersome symptoms by visual analo-
gue scales (VAS); mood by the Memorial Pain Assessment Card
(MPAC) (Fishman et al, 1987); and extent to which emotional
problems had been a bother by the WONCA scale (Scholten and
van Weel, 1992). The measures of HRQoL and symptoms were
repeated at weekly intervals for 4 weeks.
Hospital stay The length of the index admission and rates of re-
admission (until the patient’s death or study closure) were
recorded.
Satisfaction/dissatisfaction with care Patient satisfaction with
hospital care was assessed by four items derived from MacA-
dam’s Assessment of Suffering Questionnaire (MacAdman and
Smith, 1987). Patients were asked to nominate their primary
home carer for the purposes of the study. The carer was sent
a questionnaire within 3 days of the patient’s recruitment which
included the FAMCARE scale (Kristjanson, 1993), the Hospital
Anxiety and Depression scale (HADS) (Zigmond and Snaith,
1983) and some additional questions about the way in which
information and communication issues were handled in hospi-
tal. Carers were informed that they would be sent a similar
questionnaire in the future. This questionnaire was timed to
arrive 6 months after the death of the patient and consisted
of the HADS and questions relating to the use of bereavement
services.
A more detailed interview using a critical incident approach, was
carried out with the carers of all patients who were discharged
home. The interview covered satisfaction with the amount of infor-
mation given about the patient’s illness, medication, symptoms and
sources of support; acceptability of current arrangements and loca-
tion of care; expectations of future options for treatment and care
and likely sequence of events.
The patient’s GP and district nursing team were sent a letter
following recruitment explaining the study and alerting the recipi-
ent that information would be requested at a later date about the
patient’s discharge arrangements. If a patient was not discharged
from hospital no further contact was made with the primary health
care team. For those patients who were discharged home, the GP
and district nurse were interviewed by telephone, or in the case
of repeated failure to arrange this, a questionnaire was sent. The
questions covered satisfaction with the amount and type of
communication with hospital staff; appropriateness of the package
of care arranged for each patient; amount of input provided to the
patient following discharge; and use of other community services
by the patient.
Resource use data Data on resource use in the hospital setting,
by the PCT and in primary care were collected from a number of
sources as detailed in Table 1.
Sample size All new inpatient referrals to the PCT within UBHT
were considered for entry to the study. A sample size of 261
patients was required in order to detect standardised differences
in the four primary outcome variables of between 0.37 and 0.43
standard deviations with two-tailed a=0.05 and 80–90% power
at the primary (1 week) follow-up using a 2:1 (intervention:
control) randomisation ratio. It was considered that this would
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yet would be a feasible difference between the two groups in this
setting.
Randomisation
Randomisation took place after referral to the PCT: an unequal
ratio was felt to be more acceptable to ward staff and was adopted
in an attempt to facilitate recruitment. The randomisation was
stratiﬁed by hospital site with patients from the Oncology Centre
randomised separately from patients within the other hospitals of
the group in order to ensure balance in the level of care received
by patients in the study. In addition cancer and non-cancer
patients were stratiﬁed within each hospital setting.
The randomisation schedule was prepared by generating random
numbers on a computer (within Microsoft Access) in permuted
blocks of three to ensure equality of randomisation between the
strata. Randomisation details were recorded on adhesive labels
placed in opaque non-resealable envelopes. Randomisation was
undertaken by a non-clinical administrator with no involvement
in patient recruitment or assessment.
Data analysis
Established coding and data handling protocols relating to the use
of structured instruments were followed. The randomised groups
were compared on an intention to treat basis, including the use
of conﬁdence intervals. All analyses therefore included individuals
in the group to which they were randomised, regardless of whether
they subsequently switched groups. The ﬁrst stage of the analysis
used descriptive statistics to compare the groups at baseline in
respect of socio-demographic characteristics and assessments at
baseline. The primary analyses involved regression models compar-
ing the allocated groups in respect of outcomes at follow-up,
adjusting for baseline scores as covariates. The distributions of
the outcomes together with the large sample sizes enabled para-
metric methods to be employed, and the median scores at
baseline and follow-up were very similar to the means. All P-values
presented are two-tailed.
Data from the semi-structured interviews with bereaved carers
will be presented in a separate report.
RESULTS
Every consultant in UBHT (apart from the obstetricians and
paediatricians) agreed to allow patients under their care to be
admitted to the study. With a view to entry into the study, 684
consecutive new inpatient referrals were assessed during the period
July 1997 to April 2000 (Figure 1). Of these, 261 (38%) were avail-
able for randomisation. Table 2 indicates the reasons why the
remaining 423 patients were not available. These patients received
usual care from the PCT (‘full-PCT’) unless they died or were
discharged before contact could be made.
Table 3 compares the baseline characteristics of patients who
agreed to participate in the study with those who either refused
or were not suitable for inclusion. The two populations did not
differ markedly with respect to age, sex and diagnosis or primary
cancer site. However, the non-study population was more ill and
closer to death. For patients with a known date of death the mean
length of survival for study patients was 76.3 days post-referral to
the PCT (median 33 days) compared with 61.5 days for non-study
patients (median 23 days).
There were also differences between the study patients rando-
mised to ‘full-PCT’ and non-study patients in the length of time
on caseload and intensity of input from the PCT (Table 3). The
PCT had more contacts per day with non-study patients and the
difference was statistically signiﬁcant.
Baseline characteristics
The allocated groups were similar in baseline characteristics except
in gender distribution (Table 4). The prevalence of the most both-
ersome symptom volunteered by patients at the baseline assessment
was also similar in the two allocated groups (Table 5).
Primary outcomes
Table 6 shows the change in scores within allocated groups from
baseline to the week 1 assessment. These data show that there
was a highly signiﬁcant improvement in scores for all items in
the ‘full-PCT’ group and for some items in the ‘telephone-PCT’
group. However, comparison of the mean scores at 1 week adjusted
for the baseline scores revealed no statistically signiﬁcant differ-
ences between the groups. The improvements in scores for
symptom severity, mood, emotional problems and HRQoL, which
were apparent at 1 week, were, amongst survivors, sustained and
increased over the subsequent 3 weeks (Figure 2).
There was very little difference in the length of hospital stay or
rates of readmission between the two groups: length of stay 14.7
(9.4) (mean (s.d.)) days ‘full-PCT’; 13.2 (9.6) days ‘telephone-
PCT’; 0.18 (0.4) readmissions ‘full-PCT’; 0.18 (0.4) readmissions
‘telephone-PCT’.
Secondary outcomes
Patient and carer satisfaction/dissatisfaction Patients in both
treatment groups expressed high levels of satisfaction with their
hospital care and there were no apparent differences between the
groups (Table 7a,b).
Hospital resource use Hospital resource use (number of diag-
nostic images, diagnostic tests, visits from other hospital
therapists) was very similar in the two groups (data not shown).
Utilisation of GP and district nurse services One hundred and
twenty-ﬁve study patients (48%) were discharged from hospital to
their home within the study period. Patients who had been allo-
cated to ‘full-PCT’ spent on average fewer days at home than
patients in the ‘telephone-PCT’ group: 13.2 (8.1) (mean (s.d.))
‘full-PCT’; 15.9 (7.9) ‘telephone-PCT’. However, these patients also
received more GP visits per day spent at home and this was statis-
tically signiﬁcant: 0.23 (2.3) ‘full-PCT’; 0.13 (0.13) ‘telephone-
PCT’, P50.01 (t-test). Patients who received ‘full-PCT’ also
received more district nurse visits but this was not statistically
signiﬁcant: 0.45 (0.59) ‘full-PCT’; 0.34 (0.54) ‘telephone-PCT’.
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Table 1 Sources from which resource use data were collected
Type of resource use Sources of data
Hospital care
Length of stay Medical case notes
Readmissions Patient Administration System
Investigations PCT patient record forms
Referrals to other non-PCT professionals
Prescribed medicines
PCT input
Frequency and intensity of PCT activity PCT patient record forms
Primary care
Number of GP visits to patient at home During home assessments from
Number of DN visits to patient at home patient and carer
Use of social services GP and DN questionnaires
Use of other community based resources
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 87(7), 733–739GP and district nurse satisfaction GPs and district nurses were
asked about the adequacy of the notice given of the patient’s
discharge, whether a shared care form had been received by the
district nurses, and overall satisfaction with the discharge proce-
dure (timing, information, equipment planning). These data
revealed a tendency for the primary care professionals of patients
who received ‘full-PCT’ to be more satisﬁed with discharge
arrangements than those of patients in the ‘telephone-PCT’ group,
but this difference did not achieve statistical signiﬁcance.
Secondary analyses
An explanatory analysis was carried out to explore the effect of proxi-
mity to death on symptom score differences. Length of survival from
referral to the PCT to date of death or date of study closure (30 April
2000) was calculated and the population of study patients divided
according to whether death occurred within 28 days of referral or
not. The difference between the randomised groups in symptom
severity at one week was not inﬂuenced by proximity to death.
Non receipt of allocated intervention Nineteen patients
switched from ‘telephone-PCT’ to ‘full-PCT’ during the course of
the study (10 within the ﬁrst week) and two patients switched in
the other direction (both in the ﬁrst week). The decision to switch
intervention groups was only taken after consultation between the
patient’s referring team and senior medical PCT staff and was
discouraged as far as possible. When a patient did switch groups
it was usually because the ward staff felt that they needed more
help with the patient’s care, particularly symptom control and
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New inpatient referrals to PCT
n=684
Not randomised
n=423
(62%)
175 allocated to ‘full-PCT’
(173 (99%) received service as
allocated)
Followed up:
1 week:
129 patients out of 160 still alive
(31 patients missed follow-up)*
2 weeks:
95 patients out of 146 still alive
(51 patients missed follow-up)*
3 weeks:
79 patients out of 133 still alive
(54 patients missed follow-up)*
4 weeks:
76 patients out of 118 still alive
(42 patients missed follow-up)*
Followed up:
1 week:
62 patients out of 75 still alive
(13 patients missed follow-up)*
2 weeks:
44 patients out of 68 still alive
(24 patients missed follow-up)*
3 weeks:
38 patients out of 59 still alive
(21 patients missed follow-up)*
4 weeks:
33 patients out of 49 still alive
(16 patients missed follow-up)*
86 allocated to ‘telephone-PCT’
(67 (78%) received service as
allocated)
Randomised
n=261
(38%)
* number of patients who missed follow-up at this assessment because they were too ill, tired
or just not available. Patients were often assessed at subsequent follow-up.
Figure 1 Flow of patients through the imPaCT trial
Table 2 Reasons why 423 patients were not randomised
Patient not able to give informed consent
a 150
Patient too ill and/or family too distressed to cope with study 83
Patient expressed unwillingness to answer questionnaires 44
Patient and/or family preference for PCT involvement 30
Strong preference by the ward nursing team or referring physician for
PCT involvement 26
Other reasons
b 84
No apparent reason 6
aPredominantly because of cognitive impairment.
bIncluding 40 patients expected to
be discharged within 24 h, and 12 urgent referrals of patients where there was no
time to obtain consent to the study.
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occasions because the ward staff realised that the patient had not
been prepared for face-to-face PCT input. In these two cases tele-
phone advice was regarded as more appropriate than visits (and
neither patient was ever seen by the PCT).
DISCUSSION
This is the only randomised controlled trial of a specialist hospital
advisory PCT. It has failed to show a signiﬁcant difference between
the ‘full-PCT’ and ‘telephone-PCT’ in respect of the primary
outcome measures, and particularly symptoms and HRQoL.
However, we have completed meticulously a randomised controlled
trial that provides robust, detailed and comprehensive information
about the clinical course and care of patients dying of cancer and
other chronic diseases in an acute hospital setting. We are able to
conclude from our data that in both treatment groups the manage-
ment of patients entered into the study (as reﬂected in the primary
outcome measures) was of a high standard, that their symptoms
were signiﬁcantly improved, that patients and carers were highly
satisﬁed with the care they received and the information they were
given, and that communication and liaison between the hospital
and primary care teams was good and generally of a high order.
These are important ﬁndings, irrespective of the comparison of
interventions.
In both groups there were highly signiﬁcant improvements in
bothersome symptoms and HRQoL which were apparent within
1 week and sustained for the duration of the 4 week observation
period. The usual course in such patients is one of deterioration
in physical symptoms (Coyle et al, 1990; Ventafridda et al, 1990,
Peruselli et al, 1999). There was a consistent direction to the
comparisons of the main outcome measures and satisfaction scores
in favour of ‘full-PCT’, though the differences between the groups
were not signiﬁcant. However, there was a highly signiﬁcant differ-
ence in the number of patients who switched intervention groups,
in favour of the ‘full-PCT’. It seems clear from these data that
patients in both groups were being well managed. This poses the
question as to whether either or both interventions contributed
to this good management.
Early studies completed before the development of hospice and
specialist palliative care showed that physical and psychological
symptoms were common and often inadequately treated (Hinton,
1963, 1964). Specialist services for dying patients began in the
1960s and 1970s, but the quality of care in hospitals and the
community inevitably varied in different localities. In one survey
published in 1984 of a random sample of 262 deaths, ‘a high
proportion’ had ineffectively controlled pain, cough, dyspnoea or
insomnia (Wilkes, 1984).
A large survey of family members of people who died from cancer
in the UK in 1990 indicated that pain and other symptoms in these
patients were common and caused considerable distress (Adding-
ton-Hall and McCarthy, 1995). Sixty-one per cent of patients
experienced pain in their last week of life and other symptoms
(dyspnoea, vomiting and constipation) were common and were often
not well controlled. The same study highlighted deﬁciencies in giving
information to and communication with patients and their families.
More recently, the SUPPORT study in ﬁve teaching hospitals in the
United States surveyed more than 4000 patients hospitalised with
life-threatening diagnoses. The data highlighted major problems of
unrelieved pain and failures of communication (The Support Princi-
pal Investigators, 1995). For example, for 50% of the conscious
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Table 3 Sex, age diagnosis, and survival trends of study and non-study
patients
Characteristics
Study patients
(n=261)
Non-study patients
(n=423)
Sex
Male 142 (54%) 225 (53%)
Female 119 (46%) 198 (47%)
Age
a (years)
Mean and range 68.4 (26–93) 67.5 (18–95)
Diagnosis
b
Cancer 243 (93%) 370 (88%)
Non-cancer 18 (7%) 50 (12%)
Survival trends post referral to PCT
Percentage alive at 1 week 90% 76%
Percentage alive at 2 weeks 82% 65%
Percentage alive at 3 weeks 74% 59%
Percentage alive at 4 weeks 64% 55%
Length of time on PCT caseload (d)
Mean 15.7
c 11.2
Median 12.5
c 7.0
Total PCT contacts/day (visits+
telephone calls)
0.97
c{ 1.40
{
aMissing data for age of two non-study patients.
bMissing data for diagnosis of three
non-study patients.
cFull-PCT (n=175). {p50.001, 95% CI 70.6 to 70.26 (t-test).
Table 4 Baseline characteristics of ‘full-PCT’ and ‘telephone-PCT’ pa-
tients
Characteristics
‘full-PCT’
(n=175)
‘telephone-PCT’
(n=86)
Sex
Male 103 (59%) 39 (45%)
Female 72 (41%) 47 (55%)
Age
Mean and range 68.5 (26–93) 68.5 (34–91)
Diagnosis
Cancer 163 (93%) 80 (93%)
Non-cancer 12 (7%) 6 (7%)
Baseline assessment scores (n=169–175)
mean (s.d.)
(n=83–86)
mean (s.d.)
Severity of most bothersome
symptom (:)
28.8 (26.4) 34.6 (27.3)
Global quality of life (:) 35.9 (22.5) 39.6 (23.5)
Mood (:) 51.6 (24.4) 51.0 (21.0)
Bothered by emotional
problems (;)
3.1 (1.4) 2.9 (1.3)
:=increasing score indicates improvement (0–100). ;=decreasing score indicates
improvement (1–5 for emotional problems).
Table 5 The most bothersome symptom volunteered by patients at
baseline
Symptom/problem
‘full-PCT’
n=171
a
‘telephone-PCT’
n=86
Pain (including ache, discomfort, griping,
tenderness, tightness)
91 (53%) 49 (57%)
Shortness of breath 14 (8%) 13 (15%)
Weakness (including limited mobility,
tiredness)
19 (11%) 6 (7%)
Gastrointestinal problems (constipation,
sickness, anorexia, lack of appetite,
mouth problems)
14 (8%) 9 (10%)
Worry/anxiety/depression/anger/frustration 11 (6%) 4 (5%)
Other problems (e.g. cough, infection,
swollen abdomen/legs, leg ulcer)
22 (13%) 5 (6%)
aFour ‘full-PCT’ patients could not volunteer any bothersome symptoms at the base-
line assessment.
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 87(7), 733–739patients who died in hospital, family members reported moderate or
severe pain at least half of the time. The ﬁndings in these studies have
been reﬂected in emotive and sometimes harrowing case reports
(Anonymous, 1989, 1994; Fenton, 1992) which have drawn attention
to widespread failures in management of patients dying in acute
hospitals. In contrast, the positive changes we have demonstrated
in the primary outcome measures in this study suggest that patients
received a high standard of care in both groups.
The lack of a signiﬁcant difference between the two interven-
tions may be a false negative in that there is a difference but we
have failed to show it. There are some pointers in our ﬁndings
which indicate that this may be the case. The factors which may
have contributed include the selection of an unrepresentative
sample of patients; contamination of the control group; and
insufﬁcient numbers of patients. In the planning of this study
we had anticipated all of these potential difﬁculties of conducting
an RCT which have been highlighted by others (Kane et al,
1985; Mcwhinney et al, 1994; Aranda, 2000) and had taken steps
to overcome them (the unequal randomisation ratio, broad entry
criteria, and maintenance of a high level of awareness of the
study amongst all hospital staff over a 2-year period). In spite
of this only 38% of potential patient recruits were randomised.
Our data indicate that the non-randomised patients were less
well and had a shorter survival time. Clinical activity data show
that they received more intensive input from the PCT than
either study group. It seems that we have excluded from the
study a group of patients who may be most needy in terms
of specialist palliative care and who may have been more likely
C
l
i
n
i
c
a
l
Table 6 Comparison of symptom scores at recruitment and 1 week
‘Full-PCT’
n=175
‘Telephone-PCT’
n=86
Difference in means at 1
week adjusted for base-
line
n
Mean at recruit?
mean at 1 week P
a n
Mean at recruit ?
mean at 1 week P
a
Estimate
(95% CI) P
b
Severity of most bothersome symptom : 121 28.7?48.5 50.001 56 35.1?49.3 50.001 2.94 (75.3, 11.1) 0.48
HRQoL: 117 37.1?47.3 50.001 56 39.3?45.5 0.044 2.35 (73.7, 8.4) 0.45
Mood: 117 52.1?62.2 50.001 54 51.3?59.2 0.13 3.97 (72.5, 10.4) 0.23
Bothered by emotional problems ; 124 3.2?2.6 50.001 57 3.0?1.2 0.008 0.105 (70.27, 0.48) 0.58
:=increasing score indicates improvement. ;=decreasing score indicates improvement.
aWilcoxon matched pairs signed rank tests.
bFrom regression models.
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Figure 2 Weekly mean symptom scores of those patients who com-
pleted all six assessments (n=76).
Table 7a Patient satisfaction with hospital care
‘Full-PCT’
n=175
‘Telephone-PCT’
n=86
n Mean score
a s.d. N Mean score
a s.d.
Information given about illness 127 3.5 0.82 60 3.3 0.95
Information given about treatment and medication 126 3.6 0.79 60 3.5 0.79
Availability of doctors for discussions 127 3.6 0.65 60 3.5 0.79
Availability of nurses for discussions 126 3.6 0.68 59 3.6 0.70
aResponses were scored 1 (not at all satisﬁed) to 4 (very satisﬁed).
Table 7b Carer satisfaction with hospital care
‘Full-PCT’
n=85
‘Telephone-PCT’
n=42
n
Mean
score
a s.d. n
Mean
score
a s.d.
Information giving 64 2.5 0.83 38 2.4 0.94
Availability of care 75 2.0 0.74 37 1.9 0.72
Physical patient care 72 2.1 0.71 38 2.2 0.80
Psychosocial care 64 2.3 0.78 37 2.3 0.91
aResponses were scored 1 (very satisﬁed) to 5 (very dissatisﬁed).
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challenges in palliative care research is to develop measures to
capture outcome data from such patients in a way that is prac-
tical and ethical.
The best design for this RCT would have been a comparison of
‘full-PCT’ with no input from the PCT at all. This was rejected on
ethical grounds on the basis that randomisation would take place
after referral to the PCT. Instead we decided to provide a minimal
telephone service intervention as the ‘control’, but we probably
allowed this telephone intervention to develop too far into a struc-
tured package of care in its own right.
Another factor which is likely to have inﬂuenced the care of
patients in the control group was the educational activity of the
PCT within the hospital which continued as normal throughout
the study. Regular seminars were held for oncology house staff
(who often then moved into the main hospital) and study days
were organised for nursing staff throughout the hospital. In addi-
tion the day-to-day activity of the PCT within the hospital would
have had a signiﬁcant educational inﬂuence.
The aim of the study was ambitious: to demonstrate a difference
in outcomes (if one exists) between two levels of advice and
support from a multidisciplinary PCT providing a package of care
in addition to the usual care given in a university teaching hospital.
In the light of our ‘negative’ result questions will be asked about
our trial design and in particular whether a randomised controlled
trial was the best option. We believe a RCT was the right design to
use. By imposing the rigour necessary to undertake such a study,
we have collected high quality and comprehensive data. It is not
the research paradigm which has failed, rather it is the inadequacy
of the measures in capturing outcome data from patients who are
very ill and frail.
In conclusion, we were not able to differentiate clearly in an
acute hospital setting between two models of service delivery of
specialist palliative care, partly because both were associated with
highly signiﬁcant improvements in the primary outcome measures.
Our study shows a high level of care for patients dying in this
setting in this particular group of hospitals. We believe that this
reﬂects the fact that there have been major improvements in the
last two to three decades in the way that dying patients are looked
after. These have not been implemented universally but the activity
of a specialist PCT in a general hospital is likely to raise standards
of care for such patients. We agree with Wilkes (1993), that ‘we
can look back and see that the hospice movement has irreversibly
improved the standards of care for the dying’. Our data also
demonstrate that this quality of care can be effectively provided
to patients in acute hospital beds.
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